High DPP3 concentration in the blood predicts multiple organ failure in burn patients

[News]

Diagnostics company SphingoTec GmbH ("sphingotec") and 4TEEN4 Pharmaceuticals GmbH ("4TEEN4") announced today the publication of new data showing that high blood levels of Dipeptidyl Peptidase 3 (DPP3) are indicating upcoming multiple organ failure and mortality risk in burn patients.

More... (https://www.news-medical.net/news/20200515/High-DPP3-concentration-in-the-blood-predicts-multiple-organ-failure-in-burn-patients.aspx)